Get started
Author

Biljana Tubić

Observed names: B. Tubić, Biljana K. Tubić, Biljana Tubic, Tubic Biljana, Tubic, Biljana, Tubić Biljana, Tubić, Biljana, Tubić, Biljana K.
ORCID: 0000-0002-0527-6327
Observed ORCID: 0000-0002-0527-6327
OpenAlex ID: A5086466711
Computational study of pomegranate peel extract polyphenols as potential inhibitors of SARS-CoV-2 virus internalization
2020 · Relja Suručić, Biljana Tubić, et al. · Molecular and Cellular Biochemistry · 65
PDF
Pomegranate peel extract polyphenols attenuate the SARS-CoV-2 S-glycoprotein binding ability to ACE2 Receptor: In silico and in vitro studies
2021 · Relja Suručić, Maja Travar, et al. · Bioorganic Chemistry · 63
The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future
2021 · Brian Godman, Mainul Haque, et al. · Frontiers in Public Health · 39
PDF
Prospective Risk Assessment of Medicine Shortages in Europe and Israel: Findings and Implications
2020 · Nenad Miljković, Brian Godman, et al. · Frontiers in Pharmacology · 38
PDF
Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries
2022 · Alice Pisana, Björn Wettermark, et al. · Frontiers in Pharmacology · 19
PDF
Utilisation Trend of Long‐Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications
2021 · Brian Godman, Magdalene Wladysiuk, et al. · BioMed Research International · 15
PDF
Adverse drug reaction reporting and development of pharmacovigilance systems in Bosnia and Herzegovina, Croatia, Serbia, and Montenegro: a retrospective pharmacoepidemiological study
2018 · Una Glamočlija, Biljana Tubić, et al. · Croatian Medical Journal · 14
PDF
Availability and accessibility of monoclonal antibodies in Bosnia and Herzegovina: Findings and implications
2021 · Biljana Tubic, Vanda Marković-Peković, et al. · Medicine Access Point of Care · 11
PDF
Biosimilars are essential for sustainable healthcare systems; however, key challenges remain as seen with long-acting insulin analogues
2022 · Brian Godman, Biljana Tubic, et al. · Journal of Applied Pharmaceutical Science · 9
Dissolution Profile of Nimesulide from Pharmaceutical Preparations for Oral Use
2016 · Tubić Biljana, Uzunović Alija, et al. · Acta chimica slovenica · 9
PDF
Enhanced dissolution of anticancer drug letrozole from mesoporous zeolite clinoptilolite
2023 · Radovan Kukobat, Ranko Škrbić, et al. · Journal of Colloid and Interface Science · 8
Targeted but Troubling: CYP450 Inhibition by Kinase and PARP Inhibitors and Its Clinical Implications
2025 · Martin Kondža, Josipa Bukić, et al. · Drugs and Drug Candidates · 5
PDF
Adjuvant Treatment of the Salivary Duct Carcinoma with Her2 Overexpression
2021 · Jelena Berendika, Saša Jungić, et al. · Case Reports in Oncology · 5
Green Extraction Combined with Chemometric Approach: Profiling Phytochemicals and Antioxidant Properties of Ten Species of the Lamiaceae Family
2025 · Branislava Teofilović, Emilia Gligorić, et al. · Separations · 4
PDF
Highly sensitive UHPLC—MS/MS method for quantification of ethylenediamine-N,N′-di-2-(3-cyclohexyl) propanoic acid derivatives in mouse serum
2016 · Biljana K. Tubić, Bojan D. Marković, et al. · Acta Chromatographica · 4
Estimation of passive gastrointestinal absorption and membrane retention using PAMPA test, quantitative structure-permeability and quantitative structure-retention relationship analyses of ethylenediamine-N,N'-di-2-(3-cyclohexyl)propanoic acid and 1,3-propanediamine-N,N'-di-2-(3-cyclohexyl)propanoic acid derivatives
2020 · Biljana Tubić, Vladimir Dobričić, et al. · Journal of Pharmaceutical and Biomedical Analysis · 3
Optimal duration of therapy in the first line treatment of metastatic colorectal cancer: Single center experience
2021 · Sasa Jungic, Biljana Tubic, et al. · Vojnosanitetski pregled · 2
PDF
Discovery of Membrane Permeability, Pharmacokinetics Properties and Mechanism of Action for Analogs of Ethylenediamine-N,N′-di-2-(3-Cyclohexyl)Propionic Acid and 1,3-Propandiamine-N,N′-di-2-(3-Cyclohexyl)Propionic Acid with Antiproliferative Activity Using In Vitro and In Silico Methods
2019 · Biljana Tubić, Bojan Marković, et al. · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · 2
Prediction of in vivo Bioavailibility by in vitro Characterization of Ethylenediamine Dipropanoic Acid Derivatives with Cytotoxic Activity
2018 · Biljana K. Tubić, Sandra S. Vladimirov, et al. · Acta chimica slovenica · 2
PDF
A new model to determine lipophilicity of 1,2-ethanediamine-N,N'-di-2-(3-cyclohexyl)propanoic acid and 1,3-propanediamine-N,N'-di-2-(3-cyclohexyl)propanoic acid derivatives with antiproliferative activity by combining shake flask procedure and UHPLC-MS method
2017 · B. Tubić, B. Marković, et al. · Die Pharmazie · 2
PDF
The role of biomarkers in the development of novel cancer therapies
2012 · Saša Jungić, Biljana Tubić, et al. · Drug metabolism and drug interactions · 2
Regulatory aspects of biological medicines in Bosnia and Herzegovina
2022 · Biljana Tubić, Saša Jungić · Bosnian Journal of Basic Medical Sciences · 1
PDF
A case report of malignant peripheral nerve sheath tumour of the left thigh and popliteal fossa with lungs, spleen, and brain dissemination related to neurofibromatosis type 1
2022 · Sanja Petković, Stefan Petković, et al. · Scripta Medica · 1
PDF
Pharmacovigilance for Herbal and Traditional Medicines in Bosnia and Herzegovina
2022 · Martin Kondža, Biljana Tubić · Springer eBooks · 1
Estimation of lipophilicity data for derivatives of alkandiamine-N,N’-di-2-(3-cyclohexyl) propanoic acid with potential antineoplastic activity, by UHPLC-MS method
2017 · Biljana Tubić, Bojan Marković, et al. · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · 1
Works count: 49
Citation count: 326
H-index: 9
I10-index: 8
Year
Topic
Type